NCT00083330View on ClinicalTrials.gov

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 18, 2004

Primary Completion Date

October 1, 2009

Study Completion Date

October 1, 2009

Conditions
HealthyHIV Infections
Interventions
DRUG

VRC-HIVADV014-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00083330 - Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers | Biotech Hunter | Biotech Hunter